USPSTF Recommends Screening for Domestic Violence in Pregnant, Postpartum Women
By Elana Gotkine HealthDay Reporter
TUESDAY, Oct. 29, 2024 -- The U.S. Preventive Services Task Force recommends screening for intimate partner violence (IPV) in pregnant and postpartum women and women of reproductive age. This recommendation forms the basis of a draft recommendation statement published Oct. 29.
Researchers from the Agency for Healthcare Research and Quality in Rockville, Maryland, conducted a systematic review of the evidence on screening for IPV and caregiver abuse of older or vulnerable adults. Thirty-five studies with 18,358 participants were included. The researchers found that in three randomized clinical trials with 3,759 patients comparing IPV screening to no screening, there was no significant reduction seen in IPV or improvement in quality of life or other eligible outcomes over three to 18 months; no harms of screening were reported in two trials. Nine studies reported on the accuracy of nine tools for detecting past-year IPV; among these tools, sensitivity ranged from 26 to 87 percent and specificity varied from 80 to 97 percent. The accuracy of a tool for detecting ongoing or current relationship abuse varied widely. No studies examined the benefits or harms of screening or interventions for caregiver abuse of older or vulnerable adults or the accuracy of tests to detect abuse.
Based on these findings, the USPSTF recommends that clinicians screen pregnant and postpartum women and women of reproductive age for IPV (B recommendation). In older or vulnerable adults, the USPSTF concludes that the current evidence is inadequate for assessing the balance of benefits and harms of screening for caregiver abuse and neglect (I statement).
The draft recommendation statement and evidence review have been posted for public comment. Comments can be submitted from Oct. 29 through Nov. 25, 2024.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
Specific Antiseizure Medications Associated With Major Malformations in Infants
FRIDAY, July 18, 2025 -- Maternal use of valproate, phenobarbital, and topiramate early in pregnancy is associated with an increased risk for major malformations in infants...
ENDO: Guidelines Developed for Pregnancy Care in Preexisting Diabetes
FRIDAY, July 18, 2025 -- In a joint clinical practice guideline issued by the Endocrine Society and European Society of Endocrinology, recommendations are presented for pregnancy...
Cerebroplacental Ratio Better Guides Delivery With Perceived Less Fetal Movement
THURSDAY, July 17, 2025 -- An additional ultrasound measurement to assess resistance in fetal blood vessels can improve the decision of whether to expedite birth when a woman in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.